Dermatitis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dermatitis stocks.

Dermatitis Stocks Recent News

Date Stock Title
Apr 26 KYMR Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 26 ARQT Industry Analysts Just Made A Captivating Upgrade To Their Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenue Forecasts
Apr 25 REGN AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Apr 25 REGN Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
Apr 25 REGN Regeneron (REGN) Reports Next Week: What You Should Expect
Apr 25 KYMR Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Apr 25 BHC Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
Apr 25 KYMR 20 Counties with the Highest Cancer Rates in the US
Apr 25 REGN UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Apr 25 REGN The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power
Apr 25 REGN Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Apr 25 KYMR Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2
Apr 25 REGN Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Apr 25 REGN Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Apr 25 REGN Regeneron expands in gene editing with Mammoth deal
Apr 24 REGN Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Apr 24 REGN Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Apr 24 BHC Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
Apr 24 ARQT Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
Apr 23 BHC Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
Dermatitis

Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash. In cases of short duration, there may be small blisters, while in long-term cases the skin may become thickened. The area of skin involved can vary from small to the entire body.Dermatitis is a group of skin conditions that includes atopic dermatitis, allergic contact dermatitis, irritant contact dermatitis and stasis dermatitis. The exact cause of dermatitis is often unclear. Cases may involve a combination of irritation, allergy and poor venous return. The type of dermatitis is generally determined by the person's history and the location of the rash. For example, irritant dermatitis often occurs on the hands of people who frequently get them wet. Allergic contact dermatitis occurs upon exposure to an allergen, causing a hypersensitivity reaction in the skin.Treatment of atopic dermatitis is typically with moisturizers and steroid creams. The steroid creams should generally be of mid- to high strength and used for less than two weeks at a time as side effects can occur. Antibiotics may be required if there are signs of skin infection. Contact dermatitis is typically treated by avoiding the allergen or irritant. Antihistamines may help with sleep and to decrease nighttime scratching.Dermatitis was estimated to affect 245 million people globally in 2015. Atopic dermatitis is the most common type and generally starts in childhood. In the United States, it affects about 10–30% of people. Contact dermatitis is twice as common in females than males. Allergic contact dermatitis affects about 7% of people at some point in time. Irritant contact dermatitis is common, especially among people who do certain jobs; exact rates are unclear.

Browse All Tags